JB CHEMICALS & PHARMACEUTICALS
|
|
| BOM : 506943 NSE : JBCHEPHARM | |
| LT :
Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 24,2022 |
|
Price(EOD): ₹ 1,555.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 12,023.63 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| JB CHEMICALS & PHARMACEUTICALS | 5.6% | -0.5% | -0.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.4% | -8.5% | 23.8% |
| DIVIS LABORATORIES | 4.3% | 6.7% | -12.6% |
| DR REDDYS LABORATORIES | 3.8% | 0% | -18.7% |
| CIPLA | 0.8% | -3.2% | -2.4% |
| GLAND PHARMA | 2.4% | -7.3% | -17.9% |
| PIRAMAL ENTERPRISES | 3.9% | -11% | -33.4% |
| CADILA HEALTHCARE | 5.7% | -5.1% | -45.1% |
| TORRENT PHARMACEUTICALS | 4.1% | -0.9% | -2.5% |
FUNDAMENTAL ANALYSIS OF JB CHEMICALS & PHARMACEUTICALS
[ Q(TTM): Mar2022, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF JB CHEMICALS & PHARMACEUTICALS
[As on : Jun 24,2022
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
26.84
P/E Calculated based on EPS of 57.96
[ Mar2021 - Consolidated Results ] 6.64
P/B Calculated based on Book Value of 234.17
[ Mar2021 - Consolidated Results ] 4.96
P/S Calculated based on Revenues of 2424.24 Cr
[ TTM - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
105% 202% 220% |
SHARE PRICE MOMENTUM OF JB CHEMICALS & PHARMACEUTICALS
JB CHEMICALS & PHARMACEUTICALS vs SENSEX
DEBT OF JB CHEMICALS & PHARMACEUTICALS
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2021 2020 2019 Avg_3yrs |
0.01 0.02 0.02 0.02 |
0.02 0.02 0.02 0.02 |
|
[Last Annual Data : Mar2021]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF JB CHEMICALS & PHARMACEUTICALS
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2022 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF JB CHEMICALS & PHARMACEUTICALS
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
3.98% -2.48% -9.66% 1.02% |
18.19% 0.83% -21.77% -15.71% |
| QtrlyTrend |
0 | |
| Latest Qtr: Mar2022 | ||
| Quarterly Result Analysis → | ||
JB CHEMICALS & PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.1% | -1.8% | -13% |
| S&P BSE 500 | 2.5% | -2% | -1% |
| S&P BSE ALLCAP | 2.5% | -2% | -0.8% |
| S&P BSE 400 MIDSMALLCAP | 2% | -1.6% | -1.9% |
| S&P BSE MIDSMALLCAP | 2% | -1.4% | -2% |
| S&P BSE 250 SMALLCAP | 1.8% | -2.5% | -3.9% |
| S&P BSE SMALL CAP | 1.6% | -2.4% | -1.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 50 | 3% | -1.3% | -20.6% |
| NIFTY 500 | 2.5% | -2% | -1% |
| NIFTY500 MULTICAP 50:25:25 | 2.3% | -2% | -1.3% |
| NIFTY MID SMALL400 | 2% | -1.7% | -1.6% |
| NIFTY FREE SMALL 100 | 1.8% | -2.9% | -12.9% |
| NIFTY SMALLCAP250 | 1.7% | -2.4% | -3.2% |
You may also like the below Video Courses
FAQ about JB CHEMICALS & PHARMACEUTICALS
Is JB CHEMICALS & PHARMACEUTICALS good for long term investment?
As on Jun 24,2022, the Fundamentals of JB CHEMICALS & PHARMACEUTICALS look Strong and hence it may be good for long term investment! See Financial Performance of JB CHEMICALS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is JB CHEMICALS & PHARMACEUTICALS UnderValued or OverValued?
As on Jun 24,2022, JB CHEMICALS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of JB CHEMICALS & PHARMACEUTICALS ?
As on Jun 24,2022, the Intrinsic Value of JB CHEMICALS & PHARMACEUTICALS is Rs. 515.54 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 760.61
Fair Value [Median EV / Sales Model] : Rs. 515.54
Fair Value [Median Price / Sales Model] : Rs. 486.43
Median Fair Value of JB CHEMICALS & PHARMACEUTICALS : Rs. 515.54
Is JB CHEMICALS & PHARMACEUTICALS trading at a Premium or Discount?
As on Jun 24,2022, JB CHEMICALS & PHARMACEUTICALS is trading at a Premium of 202% based on the estimates of Median Intrinsic Value!
Check out Annual Financials of Industry Peers
Check out Quarterly Results of Industry Peers
Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
